AU2003205747A1 - Thiazole derivatives and their use d2- and 5-ht1a-receptor ligands - Google Patents
Thiazole derivatives and their use d2- and 5-ht1a-receptor ligandsInfo
- Publication number
- AU2003205747A1 AU2003205747A1 AU2003205747A AU2003205747A AU2003205747A1 AU 2003205747 A1 AU2003205747 A1 AU 2003205747A1 AU 2003205747 A AU2003205747 A AU 2003205747A AU 2003205747 A AU2003205747 A AU 2003205747A AU 2003205747 A1 AU2003205747 A1 AU 2003205747A1
- Authority
- AU
- Australia
- Prior art keywords
- ht1a
- receptor ligands
- thiazole derivatives
- thiazole
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 title 1
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 150000007979 thiazole derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02005013 | 2002-03-06 | ||
| EP02005013.4 | 2002-03-06 | ||
| PCT/EP2003/001247 WO2003074518A1 (en) | 2002-03-06 | 2003-02-07 | Thiazole derivatives and their use d2- and 5-ht1a-receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003205747A1 true AU2003205747A1 (en) | 2003-09-16 |
Family
ID=27771842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003205747A Abandoned AU2003205747A1 (en) | 2002-03-06 | 2003-02-07 | Thiazole derivatives and their use d2- and 5-ht1a-receptor ligands |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR038870A1 (en) |
| AU (1) | AU2003205747A1 (en) |
| WO (1) | WO2003074518A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1408976T5 (en) | 2001-07-20 | 2011-01-10 | Psychogenics Inc | Treatment of Attention Deficit Hyperactivity Disorder (ADHD) |
| WO2023144764A1 (en) | 2022-01-29 | 2023-08-03 | Suven Life Sciences Limited | Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA954688B (en) * | 1994-06-08 | 1996-01-29 | Lundbeck & Co As H | Serotonin 5-HT1A and dopamin D2 receptor ligands |
| DE4425145A1 (en) * | 1994-07-15 | 1996-01-18 | Basf Ag | Use of thiazole and thiadiazole compounds |
| US6242448B1 (en) * | 1998-12-17 | 2001-06-05 | American Home Products Corporation | Trisubstituted-oxazole derivatives as serotonin ligands |
-
2003
- 2003-02-07 WO PCT/EP2003/001247 patent/WO2003074518A1/en not_active Ceased
- 2003-02-07 AU AU2003205747A patent/AU2003205747A1/en not_active Abandoned
- 2003-03-05 AR ARP030100725A patent/AR038870A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003074518A1 (en) | 2003-09-12 |
| AR038870A1 (en) | 2005-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002314744A1 (en) | Thiazole and other heterocyclic ligands and use thereof | |
| AU2003266321A1 (en) | Tetrahydropyrimidine-2-one derivatives and their uses | |
| PL372123A1 (en) | Thiazole derivatives | |
| AU2003302763A1 (en) | Insecticidal aminothiazole derivatives | |
| AU2002338336A1 (en) | Epothilone derivatives and methods for making and using the same | |
| AU2003249909A1 (en) | Phenoxypropenylphenyl derivatives and their use as herbicides | |
| AU2003303388A1 (en) | Triptolide derivatives and their use | |
| IL163868A0 (en) | Hermiasterlin derivatives and uses thereof | |
| AU2003292508A1 (en) | N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands | |
| PL375416A1 (en) | Thiazole derivatives | |
| AU2003216221A1 (en) | Attachment and articles using same | |
| AU2003215351A1 (en) | Common ligand mimics: thiazolidinediones and rhodanines | |
| AU2003292381A1 (en) | Naphthyridine derivatives and their use as fungicides | |
| AU2003299943A1 (en) | Heterocycles and uses thereof | |
| AU2003252057A1 (en) | Oligomeric dyes and use thereof | |
| AU2003294938A1 (en) | Epothilone derivatives | |
| AU2003297612A1 (en) | 2-substituted-3-propenamide derivatives and methods of using the same | |
| AU2003252684A1 (en) | N-acetylglucosamine derivatives and use thereof | |
| AU2003281691A1 (en) | Furoisoquinoline derivative and use thereof | |
| AU2003281698A1 (en) | 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof | |
| GB0316910D0 (en) | Fluorocombretastatin and derivatives thereof | |
| AU2003209114A1 (en) | Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands | |
| AU2003205963A1 (en) | Azaphenylalanine derivatives and their use as antithrombotic agents | |
| AU2003900495A0 (en) | Aroylhydrazone derivatives and therapeutic uses thereof | |
| AU2003268024A1 (en) | Aryl and heteroaryl morpholine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |